The impact of the COVID-19 “Infodemic” on drug-utilization behaviors: implications for pharmacovigilance

M Tuccori, I Convertino, S Ferraro, E Cappello… - Drug safety, 2020 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic that hit the world in 2020
triggered a massive dissemination of information (an “infodemic”) about the disease that was …

When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the'infodemic'surrounding COVID-19

DA Erku, SA Belachew, S Abrha… - Research in Social and …, 2021 - Elsevier
The world has faced an unprecedented challenge when coronavirus (COVID-19) emerged
as a pandemic. Millions of people have contracted the virus and a significant number of …

The role of pharmacovigilance and ISoP during the global COVID-19 pandemic

RE Chandler, D McCarthy, JC Delumeau… - Drug Safety, 2020 - Springer
Today we find ourselves living the pages of the history books of the next generation. The
global pandemic, long predicted by experts in the fields of infectious diseases and global …

Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID‐19 pandemic

L Larrouquere, M Gabin, E Poingt… - Fundamental & …, 2020 - Wiley Online Library
Abstract On March 16, 2020, the French Society of Pharmacology and Therapeutics put
online a national Question and Answer (Q&A) website, https://sfpt-fr. org/covid19 on the …

Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave

S Enners, G Gradl, M Kieble, M Böhm… - … and drug safety, 2021 - Wiley Online Library
Purpose Conflicting information on potential benefits of drugs as well as reports on
hypothetical harm of commonly used drugs in COVID‐19 treatment have challenged …

The pharmacist's active role in combating COVID-19 medication misinformation

KK Marwitz - Journal of the American Pharmacists Association, 2021 - Elsevier
Pharmacists listen to and dispel medication misinformation daily. Because of their
accessibility, pharmacists have the opportunity during pharmacist-patient interactions to …

Drug safety of frequently used drugs and substances for self-medication in COVID-19

D Baracaldo-Santamaría… - … advances in drug …, 2022 - journals.sagepub.com
During the COVID-19 pandemic, the behavior of self-medication has increased. The
dissemination of misleading information regarding the efficacy of certain drugs or …

Considerations for pharmacoepidemiological analyses in the SARS‐CoV‐2 pandemic

A Pottegård, X Kurz, N Moore… - … and Drug Safety, 2020 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19) pandemic has triggered several
hypotheses regarding use of specific medicines and risk of infection as well as prognosis …

Incidence of adverse drug reactions in COVID‐19 patients in China: an active monitoring study by hospital pharmacovigilance system

J Sun, X Deng, X Chen, J Huang… - Clinical …, 2020 - Wiley Online Library
To evaluate the incidence, type, and risk factors associated with adverse drug reactions
(ADRs) among patients with coronavirus disease 2019 (COVID‐19) by Hospital …

COVID-19 and the health of people who use drugs: What is and what could be?

J Grebely, M Cerdá, T Rhodes - International Journal of Drug Policy, 2020 - Elsevier
Abstract SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know
it, and continues to do so. How COVID-19 affects people who use drugs, the environments in …